Drug Development in Conformational Diseases: A Novel Family of Chemical Chaperones that Bind and Stabilise Several Polymorphic Amyloid Structures-Reference-Cited by-同舟云学术

Drug Development in Conformational Diseases: A Novel Family of Chemical Chaperones that Bind and Stabilise Several Polymorphic Amyloid Structures

Published:2015-09-01 Issue:9 Volume:10 Page:e0135292
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Sablón-Carrazana Marquiza,Fernández Isaac,Bencomo Alberto,Lara-Martínez Reyna,Rivera-Marrero Suchitil,Domínguez Guadalupe,Pérez-Perera Rafaela,Jiménez-García Luis Felipe,Altamirano-Bustamante Nelly F.,Diaz-Delgado Massiel,Vedrenne Fernand,Rivillas-Acevedo Lina,Pasten-Hidalgo Karina,Segura-Valdez María de Lourdes,Islas-Andrade Sergio,Garrido-Magaña Eulalia,Perera-Pintado Alejandro,Prats-Capote Anaís,Rodríguez-Tanty Chryslaine,Altamirano-Bustamante Myriam M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference51 articles.

1. Progressive disruption of cellular protein folding in models of polyglutamine diseases;T Gidalevitz;Science,2006

2. Towards a pharmacophore for amyloid;M Landau;PLOS Biol,2011

3. Role of quality control pathways in human diseases involving protein misfolding;WJ Welch;Semin Cell Dev Biol,2004

4. A primer of amyloid nomenclature;P Westermark;Amyloid,2007

5. Molecular and cellular aspects of protein misfolding and disease;E Herczenik;FASEB J,2008

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amylovis-201 is a new dual-target ligand, acting as an anti-amyloidogenic compound and a potent agonist of the σ1 chaperone protein;Acta Pharmaceutica Sinica B;2024-06

2. Amylovis-201 enhances physiological memory formation and rescues memory and hippocampal cell loss in a streptozotocin-induced Alzheimer's disease animal model;Brain Research;2024-05

3. Design and synthesis of piano-stool ruthenium(II) complexes and their studies on the inhibition of amyloid β (1–42) peptide aggregation;International Journal of Biological Macromolecules;2023-06

4. Pharmacological Inventions for Alzheimer Treatment in the United States of America: A Revision Patent from 2010 – 2020;The Journal of Prevention of Alzheimer's Disease;2023

5. Enhanced potency of aggregation inhibitors mediated by liquid condensates;Physical Review Research;2022-12-08